APO Research

APO RESEARCH · REPORT

G-protein Coupled Receptor

Selected research

Market Analysis & Forecast

Global G-protein Coupled Receptor Market Analysis and Forecast 2026-2032

Market perspective

The global G-protein Coupled Receptor market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for G-protein Coupled Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for G-protein Coupled Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for G-protein Coupled Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for G-protein Coupled Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of G-protein Coupled Receptor include Abcam plc, Becton, Dickinson, Cisbio Bioassays, DiscoveRx Corporation, EMD Millipore, Enzo Life Sciences, Inc., HD Biosciences Co. Ltd., PerkinElmer, Inc. and Promega Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for G-protein Coupled Receptor, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of G-protein Coupled Receptor, also provides the revenue of main regions and countries. Of the upcoming market potential for G-protein Coupled Receptor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the G-protein Coupled Receptor revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global G-protein Coupled Receptor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for G-protein Coupled Receptor revenue, projected growth trends, production technology, application and end-user industry.

G-protein Coupled Receptor Segment by Company

Abcam plc

Becton, Dickinson

Cisbio Bioassays

DiscoveRx Corporation

EMD Millipore

Enzo Life Sciences, Inc.

HD Biosciences Co. Ltd.

PerkinElmer, Inc.

Promega Corporation

Qiagen

AbbVie

Thermo Fisher Scientific, Inc.

Abbott

G-protein Coupled Receptor Segment by Type

cAMP Assays

cGMP Assays

GTPγS Binding Assays

Reporter Gene Assays

Calcium Level Detection Assays

Receptor Internalization Assays

G-protein Coupled Receptor Segment by Application

Oncology

Central Nervous System

Cardiovascular System

Reproductive System

Immune System

Respiratory System

Others

G-protein Coupled Receptor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global G-protein Coupled Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of G-protein Coupled Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of G-protein Coupled Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of G-protein Coupled Receptor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of G-protein Coupled Receptor company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, G-protein Coupled Receptor revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global G-protein Coupled Receptor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. cAMP Assays Major Player Table 3. cGMP Assays Major Player Table 4. GTPγS Binding Assays Major Player Table 5. Reporter Gene Assays Major Player Table 6. Calcium Level Detection Assays Major Player Table 7. Receptor Internalization Assays Major Player Table 8. Global G-protein Coupled Receptor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Oncology Major Player Table 10. Central Nervous System Major Player Table 11. Cardiovascular System Major Player Table 12. Reproductive System Major Player Table 13. Immune System Major Player Table 14. Respiratory System Major Player Table 15. Others Major Player Table 16. G-protein Coupled Receptor Industry Trends Table 17. G-protein Coupled Receptor Industry Drivers Table 18. G-protein Coupled Receptor Industry Opportunities and Challenges Table 19. G-protein Coupled Receptor Industry Restraints Table 20. Global G-protein Coupled Receptor Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 21. Global G-protein Coupled Receptor Market Size by Region (2021-2026) & (US$ Million) Table 22. Global G-protein Coupled Receptor Market Share by Region (2021-2026) Table 23. Global G-protein Coupled Receptor Market Size by Region (2027-2032) & (US$ Million) Table 24. Global G-protein Coupled Receptor Market Share by Region (2027-2032) Table 25. Global G-protein Coupled Receptor Revenue by Players (US$ Million) & (2021-2026) Table 26. Global G-protein Coupled Receptor Revenue Market Share by Players (2021-2026) Table 27. Global G-protein Coupled Receptor Key Players Ranking, 2024 VS 2025 VS 2026 Table 28. Global G-protein Coupled Receptor Key Players Headquarters & Area Served Table 29. Global G-protein Coupled Receptor Players, Product Type & Application Table 30. Global G-protein Coupled Receptor Players Establishment Date Table 31. Global Players Market Concentration Ratio (CR5 and HHI) Table 32. Global G-protein Coupled Receptor by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global G-protein Coupled Receptor Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global G-protein Coupled Receptor Revenue by Type (2021-2026) & (US$ Million) Table 35. Global G-protein Coupled Receptor Revenue by Type (2027-2032) & (US$ Million) Table 36. Global G-protein Coupled Receptor Revenue Market Share by Type (2021-2026) Table 37. Global G-protein Coupled Receptor Revenue Market Share by Type (2027-2032) Table 38. Global G-protein Coupled Receptor Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global G-protein Coupled Receptor Revenue by Application (2021-2026) & (US$ Million) Table 40. Global G-protein Coupled Receptor Revenue by Application (2027-2032) & (US$ Million) Table 41. Global G-protein Coupled Receptor Revenue Market Share by Application (2021-2026) Table 42. Global G-protein Coupled Receptor Revenue Market Share by Application (2027-2032) Table 43. Abcam plc Company Information Table 44. Abcam plc Business Overview Table 45. Abcam plc G-protein Coupled Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Abcam plc G-protein Coupled Receptor Product Portfolio Table 47. Abcam plc Recent Development Table 48. Becton, Dickinson Company Information Table 49. Becton, Dickinson Business Overview Table 50. Becton, Dickinson G-protein Coupled Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Becton, Dickinson G-protein Coupled Receptor Product Portfolio Table 52. Becton, Dickinson Recent Development Table 53. Cisbio Bioassays Company Information Table 54. Cisbio Bioassays Business Overview Table 55. Cisbio Bioassays G-protein Coupled Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Cisbio Bioassays G-protein Coupled Receptor Product Portfolio Table 57. Cisbio Bioassays Recent Development Table 58. DiscoveRx Corporation Company Information Table 59. DiscoveRx Corporation Business Overview Table 60. DiscoveRx Corporation G-protein Coupled Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. DiscoveRx Corporation G-protein Coupled Receptor Product Portfolio Table 62. DiscoveRx Corporation Recent Development Table 63. EMD Millipore Company Information Table 64. EMD Millipore Business Overview Table 65. EMD Millipore G-protein Coupled Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. EMD Millipore G-protein Coupled Receptor Product Portfolio Table 67. EMD Millipore Recent Development Table 68. Enzo Life Sciences, Inc. Company Information Table 69. Enzo Life Sciences, Inc. Business Overview Table 70. Enzo Life Sciences, Inc. G-protein Coupled Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Enzo Life Sciences, Inc. G-protein Coupled Receptor Product Portfolio Table 72. Enzo Life Sciences, Inc. Recent Development Table 73. HD Biosciences Co. Ltd. Company Information Table 74. HD Biosciences Co. Ltd. Business Overview Table 75. HD Biosciences Co. Ltd. G-protein Coupled Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. HD Biosciences Co. Ltd. G-protein Coupled Receptor Product Portfolio Table 77. HD Biosciences Co. Ltd. Recent Development Table 78. PerkinElmer, Inc. Company Information Table 79. PerkinElmer, Inc. Business Overview Table 80. PerkinElmer, Inc. G-protein Coupled Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. PerkinElmer, Inc. G-protein Coupled Receptor Product Portfolio Table 82. PerkinElmer, Inc. Recent Development Table 83. Promega Corporation Company Information Table 84. Promega Corporation Business Overview Table 85. Promega Corporation G-protein Coupled Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Promega Corporation G-protein Coupled Receptor Product Portfolio Table 87. Promega Corporation Recent Development Table 88. Qiagen Company Information Table 89. Qiagen Business Overview Table 90. Qiagen G-protein Coupled Receptor Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. Qiagen G-protein Coupled Receptor Product Portfolio Table 92. Qiagen Recent Development Table 93. AbbVie Company Information Table 94. AbbVie Business Overview Table 95. AbbVie G-protein Coupled Receptor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. AbbVie G-protein Coupled Receptor Product Portfolio Table 97. AbbVie Recent Development Table 98. Thermo Fisher Scientific, Inc. Company Information Table 99. Thermo Fisher Scientific, Inc. Business Overview Table 100. Thermo Fisher Scientific, Inc. G-protein Coupled Receptor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Thermo Fisher Scientific, Inc. G-protein Coupled Receptor Product Portfolio Table 102. Thermo Fisher Scientific, Inc. Recent Development Table 103. Abbott Company Information Table 104. Abbott Business Overview Table 105. Abbott G-protein Coupled Receptor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Abbott G-protein Coupled Receptor Product Portfolio Table 107. Abbott Recent Development Table 108. North America G-protein Coupled Receptor Revenue by Type (2021-2026) & (US$ Million) Table 109. North America G-protein Coupled Receptor Revenue by Type (2027-2032) & (US$ Million) Table 110. North America G-protein Coupled Receptor Revenue by Application (2021-2026) & (US$ Million) Table 111. North America G-protein Coupled Receptor Revenue by Application (2027-2032) & (US$ Million) Table 112. North America G-protein Coupled Receptor Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. North America G-protein Coupled Receptor Revenue by Country (2021-2026) & (US$ Million) Table 114. North America G-protein Coupled Receptor Revenue by Country (US$ Million) & (2027-2032) Table 115. Europe G-protein Coupled Receptor Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe G-protein Coupled Receptor Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe G-protein Coupled Receptor Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe G-protein Coupled Receptor Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe G-protein Coupled Receptor Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Europe G-protein Coupled Receptor Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe G-protein Coupled Receptor Revenue by Country (US$ Million) & (2027-2032) Table 122. China G-protein Coupled Receptor Revenue by Type (2021-2026) & (US$ Million) Table 123. China G-protein Coupled Receptor Revenue by Type (2027-2032) & (US$ Million) Table 124. China G-protein Coupled Receptor Revenue by Application (2021-2026) & (US$ Million) Table 125. China G-protein Coupled Receptor Revenue by Application (2027-2032) & (US$ Million) Table 126. Asia G-protein Coupled Receptor Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia G-protein Coupled Receptor Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia G-protein Coupled Receptor Revenue by Application (2021-2026) & (US$ Million) Table 129. Asia G-protein Coupled Receptor Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia G-protein Coupled Receptor Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Asia G-protein Coupled Receptor Revenue by Region (US$ Million) & (2021-2026) Table 132. Asia G-protein Coupled Receptor Revenue by Region (US$ Million) & (2027-2032) Table 133. SAMEA G-protein Coupled Receptor Revenue by Type (2021-2026) & (US$ Million) Table 134. SAMEA G-protein Coupled Receptor Revenue by Type (2027-2032) & (US$ Million) Table 135. SAMEA G-protein Coupled Receptor Revenue by Application (2021-2026) & (US$ Million) Table 136. SAMEA G-protein Coupled Receptor Revenue by Application (2027-2032) & (US$ Million) Table 137. SAMEA G-protein Coupled Receptor Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. SAMEA G-protein Coupled Receptor Revenue by Country (2021-2026) & (US$ Million) Table 139. SAMEA G-protein Coupled Receptor Revenue by Country (US$ Million) & (2027-2032) Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. G-protein Coupled Receptor Image Figure 2. Global G-protein Coupled Receptor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global G-protein Coupled Receptor Market Size Share 2021 VS 2025 VS 2032 Figure 4. cAMP Assays Image Figure 5. cGMP Assays Image Figure 6. GTPγS Binding Assays Image Figure 7. Reporter Gene Assays Image Figure 8. Calcium Level Detection Assays Image Figure 9. Receptor Internalization Assays Image Figure 10. Global G-protein Coupled Receptor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global G-protein Coupled Receptor Market Size Share 2021 VS 2025 VS 2032 Figure 12. Oncology Image Figure 13. Central Nervous System Image Figure 14. Cardiovascular System Image Figure 15. Reproductive System Image Figure 16. Immune System Image Figure 17. Respiratory System Image Figure 18. Others Image Figure 19. Global G-protein Coupled Receptor Market Size (US$ Million) & (2021-2032) Figure 20. Global G-protein Coupled Receptor Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 21. Global G-protein Coupled Receptor Market Share by Region: 2021 VS 2025 VS 2032 Figure 22. Global G-protein Coupled Receptor Players Revenue Share Top 10 and Top 5 in 2025 Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global G-protein Coupled Receptor Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global G-protein Coupled Receptor Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global G-protein Coupled Receptor Revenue Market Share by Type (2021-2032) Figure 27. Global G-protein Coupled Receptor Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global G-protein Coupled Receptor Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 29. Global G-protein Coupled Receptor Revenue Market Share by Application (2021-2032) Figure 30. North America G-protein Coupled Receptor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. North America G-protein Coupled Receptor Revenue Share by Type (2021-2032) Figure 32. North America G-protein Coupled Receptor Revenue Share by Application (2021-2032) Figure 33. North America G-protein Coupled Receptor Revenue Share by Country (2021-2032) Figure 34. United States G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Canada G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Mexico G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Europe G-protein Coupled Receptor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 38. Europe G-protein Coupled Receptor Revenue Share by Type (2021-2032) Figure 39. Europe G-protein Coupled Receptor Revenue Share by Application (2021-2032) Figure 40. Europe G-protein Coupled Receptor Revenue Share by Country (2021-2032) Figure 41. Germany G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. France G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. U.K. G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Italy G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Spain G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Russia G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. Netherlands G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. Nordic Countries G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. China G-protein Coupled Receptor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. China G-protein Coupled Receptor Revenue Share by Type (2021-2032) Figure 51. China G-protein Coupled Receptor Revenue Share by Application (2021-2032) Figure 52. Asia G-protein Coupled Receptor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 53. Asia G-protein Coupled Receptor Revenue Share by Type (2021-2032) Figure 54. Asia G-protein Coupled Receptor Revenue Share by Application (2021-2032) Figure 55. Asia G-protein Coupled Receptor Revenue Share by Region (2021-2032) Figure 56. Japan G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. South Korea G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. India G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Australia G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Taiwan G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Southeast Asia G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. SAMEA G-protein Coupled Receptor Revenue YoY Growth (2021-2032) & (US$ Million) Figure 63. SAMEA G-protein Coupled Receptor Revenue Share by Type (2021-2032) Figure 64. SAMEA G-protein Coupled Receptor Revenue Share by Application (2021-2032) Figure 65. SAMEA G-protein Coupled Receptor Revenue Share by Country (2021-2032) Figure 66. Brazil G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Argentina G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Chile G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Colombia G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Peru G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Saudi Arabia G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Israel G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. UAE G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Turkey G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Iran G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 76. Egypt G-protein Coupled Receptor Revenue YoY Growth (US$ Million) & (2021-2032) Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • cAMP Assays
  • cGMP Assays
  • GTPγS Binding Assays
  • Reporter Gene Assays
  • Calcium Level Detection Assays
  • Receptor Internalization Assays
Applications
  • Oncology
  • Central Nervous System
  • Cardiovascular System
  • Reproductive System
  • Immune System
  • Respiratory System
  • Others
Companies covered
  • Abcam plc
  • Becton, Dickinson
  • Cisbio Bioassays
  • DiscoveRx Corporation
  • EMD Millipore
  • Enzo Life Sciences, Inc.
  • HD Biosciences Co. Ltd.
  • PerkinElmer, Inc.
  • Promega Corporation
  • Qiagen
  • AbbVie
  • Thermo Fisher Scientific, Inc.
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 G-protein Coupled Receptor Market by Type
  3. 1.2.1 Global G-protein Coupled Receptor Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 cAMP Assays
  5. 1.2.3 cGMP Assays
  6. 1.2.4 GTPγS Binding Assays
  7. 1.2.5 Reporter Gene Assays
  8. 1.2.6 Calcium Level Detection Assays
  9. 1.2.7 Receptor Internalization Assays
  10. 1.3 G-protein Coupled Receptor Market by Application
  11. 1.3.1 Global G-protein Coupled Receptor Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Oncology
  13. 1.3.3 Central Nervous System
  14. 1.3.4 Cardiovascular System
  15. 1.3.5 Reproductive System
  16. 1.3.6 Immune System
  17. 1.3.7 Respiratory System
  18. 1.3.8 Others
  19. 1.4 Assumptions and Limitations
  20. 1.5 Study Goals and Objectives
2 G-protein Coupled Receptor Market Dynamics
  1. 2.1 G-protein Coupled Receptor Industry Trends
  2. 2.2 G-protein Coupled Receptor Industry Drivers
  3. 2.3 G-protein Coupled Receptor Industry Opportunities and Challenges
  4. 2.4 G-protein Coupled Receptor Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global G-protein Coupled Receptor Market Perspective (2021-2032)
  2. 3.2 Global G-protein Coupled Receptor Growth Trends by Region
  3. 3.2.1 Global G-protein Coupled Receptor Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global G-protein Coupled Receptor Market Size by Region (2021-2026)
  5. 3.2.3 Global G-protein Coupled Receptor Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global G-protein Coupled Receptor Revenue by Players
  2. 4.1.1 Global G-protein Coupled Receptor Revenue by Players (2021-2026)
  3. 4.1.2 Global G-protein Coupled Receptor Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global G-protein Coupled Receptor Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global G-protein Coupled Receptor Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global G-protein Coupled Receptor Key Players Headquarters & Area Served
  7. 4.4 Global G-protein Coupled Receptor Players, Product Type & Application
  8. 4.5 Global G-protein Coupled Receptor Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global G-protein Coupled Receptor Market CR5 and HHI
  11. 4.6.3 2025 G-protein Coupled Receptor Tier 1, Tier 2, and Tier 3
5 G-protein Coupled Receptor Market Size by Type
  1. 5.1 Global G-protein Coupled Receptor Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global G-protein Coupled Receptor Revenue by Type (2021-2032)
  3. 5.3 Global G-protein Coupled Receptor Revenue Market Share by Type (2021-2032)
6 G-protein Coupled Receptor Market Size by Application
  1. 6.1 Global G-protein Coupled Receptor Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global G-protein Coupled Receptor Revenue by Application (2021-2032)
  3. 6.3 Global G-protein Coupled Receptor Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abcam plc
  2. 7.1.1 Abcam plc Company Information
  3. 7.1.2 Abcam plc Business Overview
  4. 7.1.3 Abcam plc G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abcam plc G-protein Coupled Receptor Product Portfolio
  6. 7.1.5 Abcam plc Recent Developments
  7. 7.2 Becton, Dickinson
  8. 7.2.1 Becton, Dickinson Company Information
  9. 7.2.2 Becton, Dickinson Business Overview
  10. 7.2.3 Becton, Dickinson G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Becton, Dickinson G-protein Coupled Receptor Product Portfolio
  12. 7.2.5 Becton, Dickinson Recent Developments
  13. 7.3 Cisbio Bioassays
  14. 7.3.1 Cisbio Bioassays Company Information
  15. 7.3.2 Cisbio Bioassays Business Overview
  16. 7.3.3 Cisbio Bioassays G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Cisbio Bioassays G-protein Coupled Receptor Product Portfolio
  18. 7.3.5 Cisbio Bioassays Recent Developments
  19. 7.4 DiscoveRx Corporation
  20. 7.4.1 DiscoveRx Corporation Company Information
  21. 7.4.2 DiscoveRx Corporation Business Overview
  22. 7.4.3 DiscoveRx Corporation G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  23. 7.4.4 DiscoveRx Corporation G-protein Coupled Receptor Product Portfolio
  24. 7.4.5 DiscoveRx Corporation Recent Developments
  25. 7.5 EMD Millipore
  26. 7.5.1 EMD Millipore Company Information
  27. 7.5.2 EMD Millipore Business Overview
  28. 7.5.3 EMD Millipore G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  29. 7.5.4 EMD Millipore G-protein Coupled Receptor Product Portfolio
  30. 7.5.5 EMD Millipore Recent Developments
  31. 7.6 Enzo Life Sciences, Inc.
  32. 7.6.1 Enzo Life Sciences, Inc. Company Information
  33. 7.6.2 Enzo Life Sciences, Inc. Business Overview
  34. 7.6.3 Enzo Life Sciences, Inc. G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Enzo Life Sciences, Inc. G-protein Coupled Receptor Product Portfolio
  36. 7.6.5 Enzo Life Sciences, Inc. Recent Developments
  37. 7.7 HD Biosciences Co. Ltd.
  38. 7.7.1 HD Biosciences Co. Ltd. Company Information
  39. 7.7.2 HD Biosciences Co. Ltd. Business Overview
  40. 7.7.3 HD Biosciences Co. Ltd. G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  41. 7.7.4 HD Biosciences Co. Ltd. G-protein Coupled Receptor Product Portfolio
  42. 7.7.5 HD Biosciences Co. Ltd. Recent Developments
  43. 7.8 PerkinElmer, Inc.
  44. 7.8.1 PerkinElmer, Inc. Company Information
  45. 7.8.2 PerkinElmer, Inc. Business Overview
  46. 7.8.3 PerkinElmer, Inc. G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  47. 7.8.4 PerkinElmer, Inc. G-protein Coupled Receptor Product Portfolio
  48. 7.8.5 PerkinElmer, Inc. Recent Developments
  49. 7.9 Promega Corporation
  50. 7.9.1 Promega Corporation Company Information
  51. 7.9.2 Promega Corporation Business Overview
  52. 7.9.3 Promega Corporation G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Promega Corporation G-protein Coupled Receptor Product Portfolio
  54. 7.9.5 Promega Corporation Recent Developments
  55. 7.10 Qiagen
  56. 7.10.1 Qiagen Company Information
  57. 7.10.2 Qiagen Business Overview
  58. 7.10.3 Qiagen G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Qiagen G-protein Coupled Receptor Product Portfolio
  60. 7.10.5 Qiagen Recent Developments
  61. 7.11 AbbVie
  62. 7.11.1 AbbVie Company Information
  63. 7.11.2 AbbVie Business Overview
  64. 7.11.3 AbbVie G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  65. 7.11.4 AbbVie G-protein Coupled Receptor Product Portfolio
  66. 7.11.5 AbbVie Recent Developments
  67. 7.12 Thermo Fisher Scientific, Inc.
  68. 7.12.1 Thermo Fisher Scientific, Inc. Company Information
  69. 7.12.2 Thermo Fisher Scientific, Inc. Business Overview
  70. 7.12.3 Thermo Fisher Scientific, Inc. G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Thermo Fisher Scientific, Inc. G-protein Coupled Receptor Product Portfolio
  72. 7.12.5 Thermo Fisher Scientific, Inc. Recent Developments
  73. 7.13 Abbott
  74. 7.13.1 Abbott Company Information
  75. 7.13.2 Abbott Business Overview
  76. 7.13.3 Abbott G-protein Coupled Receptor Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Abbott G-protein Coupled Receptor Product Portfolio
  78. 7.13.5 Abbott Recent Developments
8 North America
  1. 8.1 North America G-protein Coupled Receptor Revenue (2021-2032)
  2. 8.2 North America G-protein Coupled Receptor Revenue by Type (2021-2032)
  3. 8.2.1 North America G-protein Coupled Receptor Revenue by Type (2021-2026)
  4. 8.2.2 North America G-protein Coupled Receptor Revenue by Type (2027-2032)
  5. 8.3 North America G-protein Coupled Receptor Revenue Share by Type (2021-2032)
  6. 8.4 North America G-protein Coupled Receptor Revenue by Application (2021-2032)
  7. 8.4.1 North America G-protein Coupled Receptor Revenue by Application (2021-2026)
  8. 8.4.2 North America G-protein Coupled Receptor Revenue by Application (2027-2032)
  9. 8.5 North America G-protein Coupled Receptor Revenue Share by Application (2021-2032)
  10. 8.6 North America G-protein Coupled Receptor Revenue by Country
  11. 8.6.1 North America G-protein Coupled Receptor Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America G-protein Coupled Receptor Revenue by Country (2021-2026)
  13. 8.6.3 North America G-protein Coupled Receptor Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe G-protein Coupled Receptor Revenue (2021-2032)
  2. 9.2 Europe G-protein Coupled Receptor Revenue by Type (2021-2032)
  3. 9.2.1 Europe G-protein Coupled Receptor Revenue by Type (2021-2026)
  4. 9.2.2 Europe G-protein Coupled Receptor Revenue by Type (2027-2032)
  5. 9.3 Europe G-protein Coupled Receptor Revenue Share by Type (2021-2032)
  6. 9.4 Europe G-protein Coupled Receptor Revenue by Application (2021-2032)
  7. 9.4.1 Europe G-protein Coupled Receptor Revenue by Application (2021-2026)
  8. 9.4.2 Europe G-protein Coupled Receptor Revenue by Application (2027-2032)
  9. 9.5 Europe G-protein Coupled Receptor Revenue Share by Application (2021-2032)
  10. 9.6 Europe G-protein Coupled Receptor Revenue by Country
  11. 9.6.1 Europe G-protein Coupled Receptor Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe G-protein Coupled Receptor Revenue by Country (2021-2026)
  13. 9.6.3 Europe G-protein Coupled Receptor Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China G-protein Coupled Receptor Revenue (2021-2032)
  2. 10.2 China G-protein Coupled Receptor Revenue by Type (2021-2032)
  3. 10.2.1 China G-protein Coupled Receptor Revenue by Type (2021-2026)
  4. 10.2.2 China G-protein Coupled Receptor Revenue by Type (2027-2032)
  5. 10.3 China G-protein Coupled Receptor Revenue Share by Type (2021-2032)
  6. 10.4 China G-protein Coupled Receptor Revenue by Application (2021-2032)
  7. 10.4.1 China G-protein Coupled Receptor Revenue by Application (2021-2026)
  8. 10.4.2 China G-protein Coupled Receptor Revenue by Application (2027-2032)
  9. 10.5 China G-protein Coupled Receptor Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia G-protein Coupled Receptor Revenue (2021-2032)
  2. 11.2 Asia G-protein Coupled Receptor Revenue by Type (2021-2032)
  3. 11.2.1 Asia G-protein Coupled Receptor Revenue by Type (2021-2026)
  4. 11.2.2 Asia G-protein Coupled Receptor Revenue by Type (2027-2032)
  5. 11.3 Asia G-protein Coupled Receptor Revenue Share by Type (2021-2032)
  6. 11.4 Asia G-protein Coupled Receptor Revenue by Application (2021-2032)
  7. 11.4.1 Asia G-protein Coupled Receptor Revenue by Application (2021-2026)
  8. 11.4.2 Asia G-protein Coupled Receptor Revenue by Application (2027-2032)
  9. 11.5 Asia G-protein Coupled Receptor Revenue Share by Application (2021-2032)
  10. 11.6 Asia G-protein Coupled Receptor Revenue by Country
  11. 11.6.1 Asia G-protein Coupled Receptor Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia G-protein Coupled Receptor Revenue by Country (2021-2026)
  13. 11.6.3 Asia G-protein Coupled Receptor Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA G-protein Coupled Receptor Revenue (2021-2032)
  2. 12.2 SAMEA G-protein Coupled Receptor Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA G-protein Coupled Receptor Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA G-protein Coupled Receptor Revenue by Type (2027-2032)
  5. 12.3 SAMEA G-protein Coupled Receptor Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA G-protein Coupled Receptor Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA G-protein Coupled Receptor Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA G-protein Coupled Receptor Revenue by Application (2027-2032)
  9. 12.5 SAMEA G-protein Coupled Receptor Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA G-protein Coupled Receptor Revenue by Country
  11. 12.6.1 SAMEA G-protein Coupled Receptor Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA G-protein Coupled Receptor Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA G-protein Coupled Receptor Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research